← SynDRA
DELGOCITINIB
SynDRA canonical compound SYN0039653 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | JAK1 | JAK2 | JAK3 | TYK2 |
|---|
| Mechanism of action | JAK inhibitor |
|---|
All known targets
- JAK1
- JAK2
- JAK3
- TYK2
- LCK
- ROCK2
Mechanisms of action (all sources)
- JAK3 INHIBITOR
- Janus Kinase (JAK) inhibitor
- JAK1 INHIBITOR
- JAK2 INHIBITOR
- TYK2 INHIBITOR
- JAK inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Drug classes
- Dermatologic Agents
- Janus Kinase Inhibitors
ATC classes
- D11A · OTHER DERMATOLOGICAL PREPARATIONS
Cross-references
Synonyms
- ANZUPGO
- Anzupgo
- JTE-052
- JTE-052A
- LEO 124249
- LEO 124249A
- LP0133
- corectim
- LEO-124249
- LEO-124249A
- UNII-9L0Q8KK220
- 9L0Q8KK220
- Delgocitinib [USAN]
- Delgocitinib (JAN/USAN)
- JTE052
- GTPL9619
- SCHEMBL12547007
- HY-109053
- CS-0031558
- D11046
- Corectim
- delgocitinibum
- CHEBI:167600
- RefChem:585671
- DTXCID201767239
- Delgocitinib?
- Corectim (TN)
- Anzupgo (TN)
- ent-60
- DELGOCITINIB [INN]
- DELGOCITINIB [JAN]
- DELGOCITINIB [WHO-DD]
- Delgocitinib (JAN/USAN/INN)
- orb1308395
- SCHEMBL29360818
- YQF2710
- EX-A5577
- BDBM50545650
Look up DELGOCITINIB in the interactive SynDRA portal →